Nobody downloaded yet

Neutropenia in the Chemotherapy Patient - Essay Example

Comments (0) Cite this document
Decreasing Rates of Neutropenia in the Chemotherapy Patient Student School Course Number and Title Professor Session Decreasing Rates of Neutropenia in the Chemotherapy Patient Literature Review A review of the literature suggests that 'not only a life-threatening complication, it can also lead to a decision to reduce chemotherapy intensity in subsequent treatment cycles' (Cameron, 2009, p101), suggesting that it is important to understand the condition, how it arises and methods that can be used to lower the rate of neutropenia in the chemotherapy patient…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER92.2% of users find it useful
Neutropenia in the Chemotherapy Patient
Read TextPreview

Extract of sample "Neutropenia in the Chemotherapy Patient"

Download file to see previous pages The study by Cameron (2009) suggests that one of the most effective ways of lowering the incidence of mortality from neutropenia is educating the patients. The paper suggests that letting the patients know what the signs of (febrile) neutropenia are and how they can be recognized will allow patients to understand when to contact their healthcare provider to ensure that they receive treatment for the condition as soon as possible, lowering the mortality of the condition. There are many different side-effects of chemotherapy that can be confused with the development of neutropenia (Nirenburg et al, 2006), but patients should be informed to check for a fever over 37.5C, mouth ulcers and general malaise (Cameron, 2009). The study by Cameron (2009) then goes on to suggest that educating the healthcare providers when the risk of neutropenia is highest and the white blood cell count is likely to be lowest is most imminent during the chemotherapy course. It has been suggested that most chemotherapy treatments are most effective and thus neutropenia risk is highest at the 10-14 day stage of treatment (Hall, 2005) and thus providers and patients alike would benefit from understanding this fact. However, different chemotherapies have different apexes, and thus both patient and provider should understand that the risks may be different dependant on type of treatment received (Cameron, 2009). It has also been shown that the duration of febrile neutropenia in patients with solid tumours can be predicted (Matias et al, 2010). The only data needed to provide this information to a patient or a member of healthcare staff is the aggressiveness of the cytotoxic agents used in that chemotherapy (Matias et al, 2010). This has the benefit of allowing both patients and healthcare staff to predict the severity and duration of neutropenia before the chemotherapy is started, and if the system was imposed thoroughly it could lead to a reduction in the cases of neutropenia. It could also allow physicians to make more informed choices about the chemotherapy regimen chosen for the patients which could reduce the chances of neutropenia. There is more evidence for the development of a risk assessment tool for those at risk that may help to reduce the rates of chemotherapy-related neutropenia. Donohue (2006) has shown that giving those at risk a colony-stimulating factor (CSF) before chemotherapy is started can give the patients an increased risk of survival and reduced risks of neutropenia (p349). This is more evidence that education would be a useful factor in many situations, as nurses and physicians would need to be educated in using the risk assessment tool, and then understand the results given by this tool. However, after this it would decrease rates of neutropenia in many patients (p350) and thus achieve the goals set out by the PICO-formatted question outlined above. Crawford et al (2004) have also shown that there are assorted risk-factors for chemotherapy patients. It has been shown that 'combined cyclophosphamide, methotrexate, and 5-fluorouracil is less toxic than AC or combined cyclophosphamide, doxorubicin, and 5-fluorouraci ...Download file to see next pagesRead More
Cite this document
  • APA
  • MLA
(“Neutropenia in the Chemotherapy Patient Essay Example | Topics and Well Written Essays - 1000 words”, n.d.)
Retrieved from
(Neutropenia in the Chemotherapy Patient Essay Example | Topics and Well Written Essays - 1000 Words)
“Neutropenia in the Chemotherapy Patient Essay Example | Topics and Well Written Essays - 1000 Words”, n.d.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document

CHECK THESE SAMPLES OF Neutropenia in the Chemotherapy Patient

Neutropenia in the chemotherapy patient

...? Neutropenia in the Chemotherapy Patient EDUCATIONAL Neutropenia is a disorder characterized by a low number of neutrophils, the most important type of white blood cell and one which serves to defend against many infections (Schwenkglenks, 2011). As neutrophils have a short lifespan and a very fast turnover, they can be particularly sensitive to many types of chemotherapy (Wood & Pizzo, 1993), meaning that patients undergoing cancer treatment often present with neutropenia and the related symptoms (Kuderer et al, 2007). The concerns that come from this are numerous. Firstly, chemotherapy is a stressful time for the human body, and therefore any further weakening such as neutropenia can cause severe distress and further illness... to the...
3 Pages(750 words)Research Paper

Chemotherapy: High-Risk Complications

...anti-inflammatory drugs. Checking the patient for signs and symptoms of excess or deficit fluid volume and drug toxicity is also important. Febrile Neutropenia Febrile neutropenia is the most potential high risk complication of chemotherapy because this condition may cause even stable patients to develop hemodynamic instability and critical illness. The victim may die unless prompt monitoring and interventions are conducted. As Bolyard., Cottle., Edwards., Kinsey., Schwinzer & Zeidler (n.d) point out, neutropenia is diagnosed when the patient’s absolute neutrophil count falls below 500 cells/mm3. In...
4 Pages(1000 words)Research Paper

Cancer Chemotherapy

... without undergoing cell death," says Jack Pinski, M.D., Ph.D., assistant professor of medical oncology at USC/Norris. "Only a small percentage of cancer cells are proliferating at a time. In order for chemotherapy to be effective, it has to kill the cells while they are multiplying and dividing in the cell cycle." As well, Pack points out that some cancer cells develop a resistance to particular chemotherapeutic agents over time, decreasing their effectiveness on the disease. Chemotherapeutic agents must be tailored to an individual's cancer type because different tumors respond to different therapies. Even patients diagnosed with the same disease may require different drug combinations for treatment, Neamati says... . A...
14 Pages(3500 words)Essay

Care for a Patient undergoing Chemotherapy

...retention as evidenced by peripheral edema and weight gain. Gastrointestinal: nausea, vomiting, diarrhea, stomatitis Skin: alopecia General: hypersensitivity reactions Life-threatening Adverse Reactions Hematologic: neutropenia, leucopenia, thrombocytopenia, anemia Critical Analysis of Care For patients with advanced breast cancer who are not suitable for anthracyclines (because they are contraindicated or because of prior anthracycline treatment either in the adjuvant or metastatic setting), systemic chemotherapy should be offered, where single-agent docetaxel is the first line drug. (NICE, 2008, p.10) ___ Table 2. TRASTUZUMAB Generic Name Trastuzumab Brand...
20 Pages(5000 words)Case Study

Communication in Chemotherapy

...IS THE WAY IN WHICH WE COMMUNICATE INFORMTION TO CHEMOTHERAPY PATIENTS EFFECTIVE Word Count 9,441 IS THE WAY IN WHICH WE COMMUNICATE INFORMATION TO CHEMOTHERAPY PATIENTS EFFECTIVE TABLE OF CONTENTS I. Abstract II. Introduction A. Reason for Study B. Aim of Dissertation III. Critical Review of the Literature A. What they want to know B. When to give the information C. Patient Outcomes D. Provider Education E. Discussion 1. Questions that need to be addressed IV . Proposal A. Introduction/ Background B. Rational C. Aim C. Research approach/ Method D. Timetable E. Personnel F. Budget E. Summary/ General...
23 Pages(5750 words)Essay

Cytotoxic Chemotherapy

...Introduction to Cytotoxic Chemotherapy: A Reflective Essay Introduction: This is a reflective essay about a patient whose identity is has been intentionally kept undisclosed for ethical reasons and for reasons of confidentiality. The patient is a 40-year-old single female who was taken care of in the clinical practice. This patient had stage 1 carcinoma of the breast with no lymph node involvement at presentation. The patient underwent FEC chemotherapy for this. The chemotherapy was uneventful except for some nausea that was managed well with antiemetic medications. This reflective essay is a journey through the cytotoxic...
12 Pages(3000 words)Essay

Care of the patient having Cytotoxic Chemotherapy (GM50Z8)

...A Patient’s Guide to Chemotherapy: A Critique Patient Information Leaflets (PILs) are very essential in a patient’s life. Patients are advised to know what kind of treatment they are taking or in what condition they are now experiencing. It is a must that they know it by heart. It is their health, so to speak and it is their life. They have all the right to know everything. That is why there are consultations with the doctor. However, according to Wilson [1998], a study showed that patients forget half the doctor’s advise after five minutes they have left the consultation room. This is quite an alarming state. To think that...
12 Pages(3000 words)Essay

Neutropenia in the chemotherapy patient

...References Chabner, B., Lynch, T. J., & Longo, D. L. (2008). Harrisons manual of oncology . New York: McGraw-Hill Medical. This manual is written togive details on the vast amount of clinical information given to those administrating cancer care. The manual gives information on the medications given to those with cancer as well as information on the side-effects that these may have. The provision of information about side-effects gave a lot of information about which medications cause neutropenia in chemotherapy patients and why, which was relevant to this paper. The reliability of this source was high, because it has been published in many editions and is recommended by several clinicians. Friese, C. (2006). Chemotherapy-induced... ...
3 Pages(750 words)Annotated Bibliography

Decreasing Rates of Neutropenia in the Chemotherapy Patient

...Decreasing Rates of Neutropenia in the Chemotherapy Patient EDUCATIONAL Decreasing Rates of Neutropenia in the Chemotherapy PatientNeutropenia is a disease characterized by a low neutrophil count, which can be caused in a variety of ways. Certain medication can cause a low neutrophil count, especially those used for chemotherapy in cancer patients (Deinard et al, 1974). The primary concern for these patients is that neutropenia often means that chemotherapy treatment must be halted to prevent any further problems, and this delay may...
2 Pages(500 words)Research Paper

Chemotherapy Lounge

...Chemotherapy Lounge Question The ingenious uses a number of metaphors to portray what patients often expect and what nurses offer to their patients. The poem asserts that nurses are less compassionate since they simply administer drugs to patients and walk away leaving their patients to conjure the pain on their own. At some instance, the nurse wears a Halloween uniform in the poem a metaphor that portrays the nurse trying to disguise his identity. I felt remorseful for nurses since the poem misrepresents their roles. I understand that not every patient is always less compassionate. The fact that they attend to hundreds of patients in a day requires them to focus on their work and may always portray them as less compassionate... . ...
1 Pages(250 words)Assignment
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Essay on topic Neutropenia in the Chemotherapy Patient for FREE!

Contact Us